Expression and polymorphisms of T cell immunoglobulin domain and mucin domain protein-1 in thymoma with or without myasthenia gravis

July 2014
Oncology Letters;2014, Vol. 8 Issue 1, p317
Academic Journal
The present study aimed to investigate the expression and association of the single-nucleotide polymorphism (SNP) -1637A/G in the promoter region of the T cell immunoglobulin domain and mucin domain protein-1 (Tim-1) gene in patients diagnosed with thymoma with or without myasthenia gravis (MG). The expression of Tim-1 was detected using the streptavidin peroxidase immunohistochemical staining method on tissues obtained from thymoma patients with (n=58) and without (n=62) MG. The Tim-1 gene -1637A/G polymorphism was detected using the single allele-specific primer polymerase chain reaction. The positive rate of Tim-1 expression in thymoma patients with MG was 62.1% (32/58), which was significantly higher compared with that in thymoma patients without MG (33.9%, 21/62) (P=0.002). The genotype frequencies of GG, GA and AA in the -1637A/G polymorphism were 0.7931, 0.2069 and 0, respectively, in thymoma patients with MG, and 0.6129, 0.3871 and 0, respectively, in thymoma patients without MG. A significant difference in the genotypes between the thymoma patients with MG and those without MG was found (P=0.031). In addition, a significant difference in allele frequencies between thymoma patients with MG and those without MG (P=0.024) was observed. The high expression of Tim-1 in thymoma tissues may play an important role in the development of thymoma with MG. The -1637A/G polymorphism site of the promoter region in Tim-1 may be associated with thymoma with MG. These findings provide a basis for further genetic research of thymoma with MG.


Related Articles

  • Efficacy of perioperative high-dose prednisolone therapy during thymectomy in myasthenia gravis patients. Yoshito Yamada; Shigetoshi Yoshida; Hidemi Suzuki; Tetsuzo Tagawa; Takekazu Iwata; Teruaki Mizobuchi; Naoki Kawaguchi; Ichiro Yoshino // Journal of Cardiothoracic Surgery;2013, Vol. 8 Issue 1, p1 

    Background This study aimed to investigate the benefits of administering perioperative high-dose prednisolone in conjunction with thymectomy in patients with myasthenia gravis. Methods We retrospectively reviewed data from patients with Myasthenia Gravis Foundation of America Clinical Class I to...

  • Late recurrent thymoma in myasthenia gravis: a case series. Spillane, Jennifer; Hayward, Martin; Hirsch, Nicholas P.; Taylor, Chris; Kullmann, Dimitri M.; Howard, Robin S. // Journal of Neurology, Neurosurgery & Psychiatry;Oct2012, Vol. 83 Issue 10, p1030 

    The article presents information that 10 percent to 20 percent of patients with myasthenia gravis have a thymoma. It informs that thymomas are characterized by an indolent growth with good prognosis. It mentions that patients develop recurrent thymoma at a mean of 12 years after the initial...

  • Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis. Lopez de Lapuente, Aitzkoa; Pinto-Medel, María Jesús; Astobiza, Ianire; Alloza, Iraide; Comabella, Manuel; Malhotra, Sunny; Montalban, Xavier; Zettl, Uwe K.; Rodríguez-Antigüedad, Alfredo; Fernández, Oscar; Vandenbroeck, Koen // Multiple Sclerosis Journal;Oct2015, Vol. 21 Issue 12, p1498 

    Background: Single nucleotide polymorphisms (SNPs) near SOCS1 are associated with multiple sclerosis (MS), but the most important SNPs in the area and mechanisms by which they influence the disease are unknown. Methods: A haplotype-tagging association study was performed covering 60.5kbp around...

  • Correction: ERCC1 Single Nucleotide Polymorphism C8092A, but Not Its Expression Is Associated with Survival of Esophageal Squamous Cell Carcinoma Patients from Fujian Province, China. null, null // PLoS ONE;Dec2014, Vol. 9 Issue 12, p1 

    No abstract available.

  • Changes in regulatory T cells after rituximab in two patients with refractory myasthenia gravis. Catzola, Valentina; Battaglia, Alessandra; Buzzonetti, Alexia; Fossati, Marco; Scuderi, Flavia; Fattorossi, Andrea; Evoli, Amelia // Journal of Neurology;Aug2013, Vol. 260 Issue 8, p2163 

    A letter to the editor related to investigating changes in regulatory T cells after the application of rituximab, a monoclonal antibody in patients with myasthenia gravis (MG), T cell–dependent antibody-mediated disease of the neuromuscular transmission.

  • Thymoma associated with hypogammaglobulinaemia and pure red cell aplasia. Briones, Juan; Iruretagoyena, Mirentxu; Galindo, Héctor; Ortega, Claudia; Zoroquiain, Pablo; Valbuena, José; Acevedo, Francisco; Ocqueteau, Mauricio; Sánchez, Cesar // Ecancermedicalscience;2013, Vol. 7 Issue 361-380, p1 

    Thymomas are neoplasias that begin in the thymus and develop in the anterior mediastinum. They are commonly associated with a variety of systemic and autoimmune disorders, such as pure red cell aplasia, hypogammaglobulinaemia, pancytopaenia, collagen diseases, and, most commonly, myasthenia...

  • Up-regulated Expression of Fas Antigen in Peripheral T cell Subsets in Patients with Myasthenia Gravis. Weihua Mai; Xingwei Liu; Yunping Fan; Hanwei Liu; Hai Yu Hong; Rongrong Han; Wenying Zhou // Clinical & Investigative Medicine;2012, Vol. 35 Issue 5, pE294 

    Purpose: Recent reports have linked various autoimmune diseases to defective Fasmediated apoptosis or Fas expression. Here we aimed to determine whether Fas-mediated apoptosis is involved in the pathogenesis of myasthenia gravis (MG). Methods: The expression of Fas antigen in peripheral T cell...

  • Association study between IL-17A and IL-17F gene polymorphism and myasthenia gravis in Chinese patients. Yue, Yao-Xian; Hong, Yu; Xie, Yanchen; Hao, Hong-Jun; Sui, Yi; Gu, Chuan-Kai; Zhang, Xu; Gao, Xiang; Tang, Tian-Ping; Zhang, Xian-Jun; Wang, Qi; Li, Hai-Feng // Neurological Sciences;Jan2016, Vol. 37 Issue 1, p123 

    Alleles of IL-17A and IL-17F genes were reported to be associated with many inflammatory and autoimmune disorders in Asian patients. Serum level and mRNA of IL-17A in peripheral blood mononuclear cells were reported to be significantly higher in MG patients than in healthy controls. In...

  • Invasive Spindle Cell Thymomas (WHO Type A). Moran, Cesar A.; Kalhor, Neda; Suster, Saul // American Journal of Clinical Pathology;Nov2010, Vol. 134 Issue 5, p793 

    We report 41 cases of invasive spindle cell thymomas (World Health Organization type A). The patients were 16 women and 25 men between the ages of 38 and 80 years. Clinically, the patients had diverse symptomatology, including chest pain, cough, and dyspnea. None of the patients had a history of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics